Filing Flows › Comparisons › PLSE vs FEMY
Pulse Biosciences vs Femasys: PLSE and FEMY compared
Pulse Biosciences is the larger company: $395K of revenue in its latest quarter (Q3 2026) against $332K for Femasys (Q2 2026). Pulse Biosciences is growing faster (+359% against -19% a year earlier).
Where the money goes: PLSE and FEMY
Pulse Biosciences (PLSE) · Q3 2026
Pulse Biosciences, Q3 2026: revenue $395K (+359% year over year), net loss $23.1M, operating cash flow −$15.3M. The chart follows the revenue to costs, profit and cash.
Femasys (FEMY) · Q2 2026
Femasys, Q2 2026: revenue $332K (-19% year over year), net loss $4.5M, operating cash flow −$3.9M. The chart follows the revenue to costs, profit and cash.
| Pulse Biosciences (PLSE) | Femasys (FEMY) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $395K | $332K |
| Revenue growth, Y/Y | +359% | -19% |
| Operating margin | n/m | n/m |
| Net earnings | −$23.1M | −$4.5M |
| Operating cash flow | −$15.3M | −$3.9M |
Questions
Which is bigger, Pulse Biosciences or Femasys?
Pulse Biosciences is the larger company: $395K of revenue in its latest quarter (Q3 2026) against $332K for Femasys (Q2 2026).
Is Pulse Biosciences or Femasys growing faster?
Pulse Biosciences is growing faster (+359% against -19% a year earlier).
More: Pulse Biosciences earnings · how Pulse Biosciences makes money · Femasys earnings · how Femasys makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Aug 14, 2026). Fiscal quarters can end on different dates. Not investment advice.